Results 201 to 210 of about 19,469 (260)
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. [PDF]
Intensive Care Med Exp, 2020 Tarazan N +12 more
europepmc +1 more source
Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey. [PDF]
Anesth Pain Med (Seoul), 2019 Kim JS +8 more
europepmc +1 more source
Current Use of Neuromuscular Blocking Agents in Intensive Care Units. [PDF]
Turk J Anaesthesiol Reanim, 2019 Tezcan B, Turan S, Özgök A.
europepmc +1 more source
Neuromuscular blocking agents for acute respiratory distress syndrome. [PDF]
J Crit Care, 2019 Torbic H, Duggal A.
europepmc +1 more source
Angewandte Chemie - International Edition, 2012 Be my guest: two acyclic cucurbit[n]uril-type receptors that carry SO(3) (-) -groups bind tightly to several commonly used neuromuscular blocking agents, such as rocuronium, in aqueous solution as revealed by direct and competitive UV/Vis binding assays.
Da Ma +2 more
exaly +2 more sources
Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP)
Acta Anaesthesiologica Scandinavica, 2000 In September 1997, an international consensus conference on standardization of studies of neuromuscular blocking agents was held in Copenhagen, Denmark.
D Østergaard, F Donati, J P Kampmann
exaly +2 more sources